Anti-inflammatory agent 60 (compound 21) inhibits nitric oxide production, presenting an IC50 of 12.95 µM, and reduces iNOS, phosphorylated p65, and beta-catenin expression in a concentration-dependent manner [1].
Target:
NF-kappaB
* VAT and and shipping costs not included. Errors and price changes excepted
